Table 2.

The cleavage efficiency calculation of CRISPR/Cas9-3NLS/sgHMGA2@PDA.

Time after co-incubation	Group	No. of total clones	No. of cleavage clones		No. of no cleavage clones	Cleavage rate (%)
24 h	CRISPR/Cas9-3NLS@PDA	20	0		20	0
	CRISPR/Cas9-3NLS/sgHMGA2@PDA	74	51	≦200 bp: 6	23	68.9
				200-300 bp: 23
				≧300 bp: 22
48 h	CRISPR/Cas9-3NLS@PDA	20	0		20	0
	CRISPR/Cas9-3NLS/sgHMGA2@PDA	36	29	≦200 bp: 4	7	80.55
				200-300 bp: 18
				≧300 bp: 7
72 h	CRISPR/Cas9-3NLS@PDA	20	0		20	0
	CRISPR/Cas9-3NLS/sgHMGA2@PDA	50	41	≦200 bp: 14	9	82
				200-300 bp: 16
				≧300 bp: 11